U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula 4C8H15O2.Zr
Molecular Weight 664.038
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of ZIRCONIUM OCTANOATE

SMILES

[Zr+4].CCCCCCCC([O-])=O.CCCCCCCC([O-])=O.CCCCCCCC([O-])=O.CCCCCCCC([O-])=O

InChI

InChIKey=BPYXFMVJXTUYRV-UHFFFAOYSA-J
InChI=1S/4C8H16O2.Zr/c4*1-2-3-4-5-6-7-8(9)10;/h4*2-7H2,1H3,(H,9,10);/q;;;;+4/p-4

HIDE SMILES / InChI

Molecular Formula Zr
Molecular Weight 91.224
Charge 4
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C8H15O2
Molecular Weight 143.2035
Charge -1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
Caprylic acid and medium-chain triglycerides inhibit IL-8 gene transcription in Caco-2 cells: comparison with the potent histone deacetylase inhibitor trichostatin A.
2002-05
Development of an improved method for production of antiscorpion F(ab')2 fragment of IgG with high yield and potency.
2002-05
PCR cloning of polyhydroxyalkanoate biosynthesis genes from Burkholderia caryophylli and their functional expression in recombinant Escherichia coli.
2002-04-23
Antioxidant and cyclooxygenase activities of fatty acids found in food.
2002-04-10
AQR1 gene (ORF YNL065w) encodes a plasma membrane transporter of the major facilitator superfamily that confers resistance to short-chain monocarboxylic acids and quinidine in Saccharomyces cerevisiae.
2002-04-05
Effect of vehicles and penetration enhancers on the in vitro percutaneous absorption of tenoxicam through hairless mouse skin.
2002-04-02
Effect of protein-bound uraemic toxins on the thermodynamic characteristics of human albumin.
2002-04-01
Saturated triglycerides and fatty acids activate neutrophils depending on carbon chain-length.
2002-04
In vitro uptake of [1-14C]Octanoate in brain slices of rats: basic studies for assessing [1-11C]Octanoate as a PET tracer of glial functions.
2002-04
Acute effects of fatty acids on insulin secretion from rat and human islets of Langerhans.
2002-04
Long- and medium-chain fatty acid oxidation is increased in exercise-trained human skeletal muscle.
2002-04
Exposure of ground-rig applicators to the herbicide bromoxynil applied as a 1:1 mixture of butyrate and octanoate.
2002-04
A comparison of lipase-catalysed ester and lactone synthesis in low-water systems: analysis of optimum water activity.
2002-03-20
Substrate specificity of penicillin acylase from Streptomyces lavendulae.
2002-03-01
Albumin, bilirubin, and activated carbon: new edges of an old triangle.
2002-03
Inhibition of fatty acid synthesis in bovine mammary homogenate by palmitic acid is not a detergent effect.
2002-03
Distribution of medium-chain FA in different lipid classes after administration of specific structured TAG in rats.
2002-03
Influence of mastication on gastric emptying.
2002-03
Formation of short chain length/medium chain length polyhydroxyalkanoate copolymers by fatty acid beta-oxidation inhibited Ralstonia eutropha.
2002-02-28
Inhibition of bacterial foodborne pathogens by the lactoperoxidase system in combination with monolaurin.
2002-02-25
Polyether-polyester diblock copolymers for the preparation of paclitaxel loaded polymeric micelle formulations.
2002-02-21
Self-assembled vesicles of monocarboxylic acids and alcohols: conditions for stability and for the encapsulation of biopolymers.
2002-02-10
Mechanism for fatty acid "sparing" effect on glucose-induced transcription: regulation of carbohydrate-responsive element-binding protein by AMP-activated protein kinase.
2002-02-08
Population differences in acute skin irritation responses. Race, sex, age, sensitive skin and repeat subject comparisons.
2002-02
Cloning and molecular analysis of poly(3-hydroxyalkanoate) biosynthesis genes in Pseudomonas aureofaciens.
2002-02
Influence of polymerization conditions on the hydrolytic degradation of poly(DL-lactide) polymerized in the presence of stannous octoate or zinc-metal.
2002-02
A sensitive and simplified method to analyze free fatty acids in children with mitochondrial beta oxidation disorders using gas chromatography/mass spectrometry and dried blood spots.
2002-02
Role of substrates in the regulation of mitochondrial function in situ.
2002-01-19
The relationship between AMP-activated protein kinase activity and AMP concentration in the isolated perfused rat heart.
2002-01-18
Estimation of absorption enhancement by medium-chain fatty acids in rat large intestine.
2002-01-05
Cytochrome c catalyses the formation of pentyl radical and octanoic acid radical from linoleic acid hydroperoxide.
2002-01-01
Stability study of the anticonvulsant enaminone (E118) using HPLC and LC-MS.
2002-01-01
An automated analyzer for methylated arginines in rat plasma by high-performance liquid chromatography with post-column fluorescence reaction.
2002-01
High carbohydrate availability increases LCFA uptake and decreases LCFA oxidation in perfused muscle.
2002-01
Microfloral contamination and hydrolytic enzyme differences between monsooned and non-monsooned coffees.
2002
Measurement of gastric emptying in man using deuterated octanoic acid.
2002
Intracellular degradation of two structurally different polyhydroxyalkanoic acids accumulated in Pseudomonas putida and Pseudomonas citronellolis from mixtures of octanoic acid and 5-phenylvaleric acid.
2001-12-10
Metabolic substrates other than glucose support axon function in central white matter.
2001-12-01
The genetic basis of larval resistance to a host plant toxin in Drosophila sechellia.
2001-12
Regioisomers of octanoic acid-containing structured triacylglycerols analyzed by tandem mass spectrometry using ammonia negative ion chemical ionization.
2001-12
Effect of meal size and test duration on gastric emptying and gastric myoelectrical activity as determined with simultaneous [13C]octanoate breath test and electrogastrography in normal subjects using a muffin meal.
2001-12
Use of the 13C-octanoic acid breath test for assessment of solid-phase gastric emptying in dogs.
2001-12
An associated process for the purification of immuno globulin G, catalase, superoxide dismutase and albumin from haemolysed human placenta blood.
2001-12
Palmitate oxidation in rat hepatocytes is inhibited by foetal calf serum.
2001-11
Characterization of ochratoxin A transport by human organic anion transporters.
2001-09-21
The(13)C-octanoic acid breath test for detection of effects of meal composition on the rate of solid-phase gastric emptying in ponies.
2001-08
Purification and distribution of ghrelin: the natural endogenous ligand for the growth hormone secretagogue receptor.
2001
Biocompatible polyester macroligands: new subunits for the assembly of star-shaped polymers with luminescent and cleavable metal cores.
2001
Development of a process for the biotechnological large-scale production of 4-hydroxyvalerate-containing polyesters and characterization of their physical and mechanical properties.
2001
Comparative quantitative fatty acid analysis of triacylglycerols using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and gas chromatography.
2001
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 22:57:57 GMT 2025
Edited
by admin
on Mon Mar 31 22:57:57 GMT 2025
Record UNII
E3ZD6V9VPN
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ZIRCONIUM OCTANOATE
Systematic Name English
OCTANOIC ACID, ZIRCONIUM(4+) SALT
Preferred Name English
OCTANOIC ACID, ZIRCONIUM SALT
Systematic Name English
ZIRCONIUM TETRAOCTANOATE
Systematic Name English
OCTANOIC ACID, ZIRCONIUM(4+) SALT (4:1)
Systematic Name English
ZIRCONIUM(IV) OCTANOATE
Systematic Name English
Code System Code Type Description
EPA CompTox
DTXSID30890597
Created by admin on Mon Mar 31 22:57:57 GMT 2025 , Edited by admin on Mon Mar 31 22:57:57 GMT 2025
PRIMARY
PUBCHEM
6452564
Created by admin on Mon Mar 31 22:57:57 GMT 2025 , Edited by admin on Mon Mar 31 22:57:57 GMT 2025
PRIMARY
FDA UNII
E3ZD6V9VPN
Created by admin on Mon Mar 31 22:57:57 GMT 2025 , Edited by admin on Mon Mar 31 22:57:57 GMT 2025
PRIMARY
CAS
18312-04-4
Created by admin on Mon Mar 31 22:57:57 GMT 2025 , Edited by admin on Mon Mar 31 22:57:57 GMT 2025
NON-SPECIFIC STOICHIOMETRY
CAS
5206-47-3
Created by admin on Mon Mar 31 22:57:57 GMT 2025 , Edited by admin on Mon Mar 31 22:57:57 GMT 2025
PRIMARY
ECHA (EC/EINECS)
242-197-8
Created by admin on Mon Mar 31 22:57:57 GMT 2025 , Edited by admin on Mon Mar 31 22:57:57 GMT 2025
PRIMARY